BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Olpasiran readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Olpasiran\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05581303-1039@assetmemo.bio
DTSTAMP:20261121T004046Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Olpasiran: Phase 3 readout est. (NCT05581303)
DESCRIPTION:Olpasiran\, phase 3\, Atherosclerotic Cardiovascular Disease.\n
 Study: Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduct
 ion (OCEAN(a)) - Outcomes Trial\nEstimated primary completion: 31 March 20
 28. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/olpasiran#upcomin
 g-events\nRegistry record: https://clinicaltrials.gov/study/NCT05581303
URL:https://assetmemo.bio/drug/olpasiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07293260-1039@assetmemo.bio
DTSTAMP:20261121T004046Z
DTSTART;VALUE=DATE:20280615
DTEND;VALUE=DATE:20280616
SUMMARY:Olpasiran: Phase 3 readout est. (NCT07293260)
DESCRIPTION:Olpasiran\, phase 3\, Atherosclerotic Cardiovascular Disease.\n
 Study: Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduct
 ion - Coronary Computed Tomography Angiography Trial\nEstimated primary co
 mpletion: 15 June 2028. This is a ClinicalTrials.gov estimate\, not a conf
 irmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/dr
 ug/olpasiran#upcoming-events\nRegistry record: https://clinicaltrials.gov/
 study/NCT07293260
URL:https://assetmemo.bio/drug/olpasiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07136012-1039@assetmemo.bio
DTSTAMP:20261121T004046Z
DTSTART;VALUE=DATE:20311020
DTEND;VALUE=DATE:20311021
SUMMARY:Olpasiran: Phase 3 readout est. (NCT07136012)
DESCRIPTION:Olpasiran\, phase 3\, Atherosclerotic Cardiovascular Disease.\n
 Study: OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And L
 ipoprotein(a) Reduction to Prevent First Major Cardiovascular Events\nEsti
 mated primary completion: 20 October 2031. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/olpasiran#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07136012
URL:https://assetmemo.bio/drug/olpasiran#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
